Article info
Case report
Meropenem, rifampicin and gentamicin combination therapy in a patient with complicated urinary tract infection caused by extreme drug-resistant P. aeruginosa
- Correspondence to Dolunay Merve Fakioğlu, Department of Clinical Pharmacy, Gazi University, Faculty of Pharmacy, Ankara, Turkey; dolunaytopuz90{at}gmail.com
Citation
Meropenem, rifampicin and gentamicin combination therapy in a patient with complicated urinary tract infection caused by extreme drug-resistant P. aeruginosa
Publication history
- Received January 17, 2019
- Accepted April 8, 2019
- First published July 13, 2019.
Online issue publication
February 21, 2020
Article Versions
- Previous version (13 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.